ATOSSA THERAPEUTICS, INC. Quarterly Depreciation in USD from Q1 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Atossa Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2012 to Q1 2024.
  • Atossa Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $5K, a 66.7% increase year-over-year.
  • Atossa Therapeutics, Inc. annual Depreciation for 2023 was $23K, a 188% increase from 2022.
  • Atossa Therapeutics, Inc. annual Depreciation for 2022 was $8K, a 20% decline from 2021.
  • Atossa Therapeutics, Inc. annual Depreciation for 2021 was $10K, a 47.4% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $5K +$2K +66.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $3K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2018 $19K $2.73K -$6.94K -71.8% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $26K $2.97K -$33.6K -91.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 $59.6K $4.55K -$25.1K -84.7% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $84.7K $8.77K -$24K -73.2% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $109K $9.66K -$17K -63.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 $126K $36.6K +$22.7K +163% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-08
Q3 2016 $103K $29.7K -$2.92K -8.96% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $106K $32.7K +$19.5K +147% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $86.4K $26.6K +$13.3K +100% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $73.1K $13.9K -$65.3K -82.4% Oct 1, 2015 Dec 31, 2015 10-K/A 2017-03-21
Q3 2015 $138K $32.6K +$7.98K +32.4% Jul 1, 2015 Sep 30, 2015 10-Q/A 2017-03-21
Q2 2015 $130K $13.3K -$6.59K -33.2% Apr 1, 2015 Jun 30, 2015 10-Q/A 2017-03-21
Q1 2015 $137K $13.3K -$7.89K -37.3% Jan 1, 2015 Mar 31, 2015 10-Q/A 2017-03-21
Q4 2014 $145K $79.2K +$59K +291% Oct 1, 2014 Dec 31, 2014 10-K 2015-03-30
Q3 2014 $85.9K $24.6K -$2.52K -9.28% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $88.5K $19.9K -$10.8K -35.2% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-12
Q1 2014 $99.3K $21.2K +$16.3K +335% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 $83K $20.3K Oct 1, 2013 Dec 31, 2013 10-K 2015-03-30
Q3 2013 $27.2K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $30.7K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 $4.87K +$546 +12.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q1 2012 $4.32K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.